Notch signaling as a therapeutic target in cancer: A new approach to the development of cell fate modifying agents

Oncogene

Volumn 22, Issue 43, 2003, Pages 6598-6608

  Nickoloff, Brian J ^a   Osborne, Barbara A ^b   Miele, Lucio ^c  

^a LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cancer; Leukemia; Notch; Signalling; Therapeutic targets

Indexed keywords

ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; FUCOSYLTRANSFERASE; GAMMA SECRETASE; GLYCOSYLTRANSFERASE INHIBITOR; NOTCH RECEPTOR; OLIGOPEPTIDE; RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR;

ANTINEOPLASTIC ACTIVITY; CANCER; CELL DIFFERENTIATION; CELL FATE; CELL RENEWAL; DRUG EFFECT; DRUG EFFICACY; HUMAN; LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL;

EID: 0242456129     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206758     Document Type: Review

References (137)

1. Allman D, Punt JA, Izon DJ, Aster JC and Pear WS. (2002). Cell, 109 (Suppl), S1-S11.
2. Anderson AC, Robey EA and Huang YH. (2001). Curr. Opin. Genet. Dev., 11, 554-560.
3. Apelqvist A, Li H, Sommer L, Beatus P, Anderson DJ, Honjo T, Hrabe dA, Lendahl U and Edlund H. (1999). Nature, 400, 877-881.
4. Artavanis-Tsakonas S, Rand MD and Lake RJ. (1999). Science, 284, 770-776.
5. Axelrod JD, Matsuno K, Artavanis-Tsakonas S and Perrimon N. (1996). Science, 271, 1826-1832.
6. Beatus P, Lundkvist J, Oberg C and Lendahl U. (1999). Development, 126, 3925-3935.
7. Beatus P, Lundkvist J, Oberg C, Pedersen K and Lendahl U. (2001). Mech. Dev., 104, 3-20.
8. Bellavia D, Campese AF, Alesse E, Vacca A, Felli MP, Balestri A, Stoppacciaro A, Tiveron C, Tatangelo L, Giovarelli M, Gaetano C, Ruco L, Hoffman ES, Hayday AC, Lendahl U, Frati L, Gulino A and Screpanti I. (2000). EMBO J., 19, 3337-3348.
9. Berezovska O, McLean P, Knowles R, Frosh M, Lu FM, Lux SE and Hyman BT. (1999). Neuroscience, 93, 433-439.
10. Berezovska O, Xia MQ and Hyman BT. (1998). J. Neuropathol Exp. Neurol., 57, 738-745.
11. Berset T, Hoier EF, Battu G, Canevascini S and Hajnal A. (2001). Science, 291, 1055-1058.
12. Blair SS. (1996). Science, 271, 1822-1823.
13. Blaumueller CM, Qi H, Zagouras P and Artavanis-Tsakonas S. (1997). Cell, 90, 281-291.
14. Bocchetta M, Miele L, Pass HI and Carbone M. (2003). Oncogene, 22, 81-89.
15. Brou C, Logeat F, Gupta N, Bessia C, LeBail O, Doedens JR, Cumano A, Roux P, Black RA and Israel A. (2000). Mol. Cell, 5, 207-216.
16. Callahan R and Raafat A. (2001). J. Mammary Gland Biol. Neoplasia, 6, 23-36.
17. Capobianco AJ, Zagouras P, Blaumueller CM, Artavanis-Tsakonas S and Bishop JM. (1997). Mol. Cell. Biol., 17, 6265-6273.
18. Carmena A, Buff E, Halfon MS, Gisselbrecht S, Jimenez F, Baylies MK and Michelson AM. (2002). Dev. Biol., 244, 226-242.
19. Chaturvedi V, Qin J-Z, Denning MF, Miele L and Nickoloff BJ. (2003). J. Invest. Dermatol (in press).
20. Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM and Sherr CJ. (1999). EMBO J., 18, 1571-1583.
21. Cheng P, Zlobin A, Volgina V, Gottipati S, Osborne B, Simel EJ, Miele L and Gabrilovich DI. (2001). J. Immunol., 167, 4458-4467.
22. Dang TP, Gazdar AF, Virmani AK, Sepetavec T, Hande KR, Minna JD, Roberts JR and Carbone DP. (2000). J. Natl. Cancer Inst., 92, 1355-1357.
23. Daniel B, Rangarajan A, Mukherjee G, Vallikad E and Krishna S. (1997). J. Gen. Virol., 78, 1095-1101.
24. Deftos ML, Huang E, Ojala EW, Forbush KA and Bevan MJ. (2000). Immunity, 13, 73-84.
25. Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD and Sklar J. (1991). Cell, 66, 649-661.
26. Engel I and Murre C. (2002). Proc. Natl. Acad. Sci. USA, 99, 11322-11327.
27. Felli MP, Maroder M, Mitsiadis TA, Campese AF, Bellavia D, Vacca A, Mann RS, Frati L, Lendahl U, Gulino A and Screpanti I. (1999). Int. Immunol., 11, 1017-1025.
28. Fitzgerald K. Harrington A and Leder P. (2000). Oncogene, 19, 4191-4198.
29. Foltz DR, Santiago MC, Berechid BE and Nye JS. (2002). Curr. Biol., 12, 1006-1011.
30. Fortini ME. (2000). Nature, 406, 357-358.
31. Fowlkes BJ and Robey EA. (2002). J. Immunol., 169, 1817-1821.
32. Gailani MR and Bale AE. (1999). Adv. Dermatol., 14, 261-283.
33. Garces C, Ruiz-Hidalgo MJ, Font de Mora J, Park C, Miele L, Goldstein J, Bonvini E, Porras A and Laborda J. (1997). J. Biol. Chem., 272, 29729-29734.
34. Gartel AL and Tyner AL. (2002). Mol. Cancer Ther., 1, 639-649.
35. Grandbarbe L, Bouissac J, Rand M, Hrabe dA, Artavanis-Tsakonas S and Mohier E. (2003). Development, 130, 1391-1402.
36. Greenwald I. (1998). Genes Dev., 12, 1751-1762.
37. Hendrix MJ, Seftor RE, Seftor EA, Gruman LM, Lee LM, Nickoloff BJ, Miele L, Sheriff DD and Schatteman GC. (2002). Cancer Res., 62, 665-668.
38. Hsieh JJ, Henkel T, Salmon P, Robey E, Peterson MG and Hayward SD. (1996). Mol. Cell. Biol., 16, 952-959.
39. Hsieh JJ, Zhou S, Chen L, Young DB and Hayward SD. (1999). Proc. Natl. Acad. Sci. USA, 96, 23-28.
40. Hu Y, Baud V, Oga T, Kim KI, Yoshida K and Karin M. (2001). Nature, 410, 710-714.
41. Hubmann R, Schwarzmeier JD, Shehata M, Hilgarth M, Duechler M, Dettke M and Berger R. (2002). Blood, 99, 3742-3747.
42. Ikeya T and Hayashi S. (1999). Development, 126, 4455-4463.
43. Ingles-Esteve J, Espinosa LL, Milner LA, Caelics C and Bigas A. (2001). J. Biol. Chem., 276, 44873-44880.
44. Ishii H, Nakazawa M, Yoshino S, Nakamura H, Nishioka K and Nakajima T. (2001). Rheumatol. Int., 21, 10-14.
45. Izon DJ, Punt JA and Pear WS. (2002). Curr. Opin. Immunol. 14, 192-199.
46. Jang M-S, Zlobin A and Miele L. (2000). Curr. Opin. Mol. Therap., 2, 55-65.
47. Jeffries S and Capobianco AJ. (2000). Mol. Cell Biol., 20, 3928-3941.
48. Jehn BM, Bielke W, Pear WS and Osborne BA. (1999). J. Immunol., 162, 635-638.
49. Jehn BM, Dittert I, Beyer S, von der MK and Bielke W. (2002). J. Biol. Chem., 277, 8033-8040.
50. Johnson J, Espinoza T, McGaughey RW, Rawls A and Wilson-Rawls J. (2001). Mech. Dev., 109, 355-361.
51. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cecillion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM, Weissenbach J, Bach JF, Bousser MG and Tournier-Lasserve E. (1996). Nature, 383, 707-710.
52. Jundt F, Anagnostopoulos I, Forster R, Mathas S, Stein H and Dorken B. (2002). Blood, 99, 3398-3403.
53. Kao HY, Ordentlich P, Koyano-Nakagawa N, Tang Z, Downes M, Kintner CR, Evans RM and Kadesch T. (1998). Genes Dev., 12, 2269-2277.
54. Kortschak RD, Tamme R and Lardelli M. (2001). Dev. Genes Evol., 211, 350-354.
55. Krebs LT, Xue Y, Norton CR, Shutter JR, Maguire M, Sundberg JP, Gallahan D, Closson V, Kitajewski J, Callahan R, Smith GH, Stark KL and Gridley T. (2000a). Genes Dev., 14, 1343-1352.
56. Krebs LT, Xue Y, Norton CR, Shutter JR, Maguire M, Sundberg JP, Gallahan D, Closson V, Kitajewski J, Callahan R, Smith GH, Stark KL and Gridley T. (2000b). Genes Dev., 14, 1343-1352.
57. Kumano K, Chiba S, Shimizu K, Yamagata T, Hosoya N, Saito T, Takahashi T, Hamada Y and Hirai H. (2001). Blood, 98, 3283-3289.
58. Kurooka H and Honjo T. (2000). J. Biol. Chem., 275, 17211-17220.
59. Leethanakul C, Patel V, Gillespie J, Pallente M, Ensley JF, Koontongkaew S, Liotta LA, Emmert-Buck M and Gutkind JS. (2000). Oncogene, 19, 3220-3224.
60. Leong KG, Hu X, Li L, Noseda M, Larrivee B, Hull C, Hood L, Wong F and Karsan A. (2002). Mol. Cell. Biol., 22, 2830-2841.
61. Lewis J. (1998). Nature, 393, 304-305.
62. Li Q, Lu Q, Hwang JY, Buscher D, Lee KF, Izpisua-Belmonte JC and Verma IM. (1999). Genes Dev., 13, 1322-1328.
63. Li L, Milner LA, Deng Y, Iwata M, Banta A, Graf L, Marcovina S, Friedman C, Trask BJ, Hood L and Torok-Storb B. (1998). Immunity, 8, 43-55.
64. Liu ZJ, Shirakawa T, Li Y, Soma A, Oka M, Dotto GP, Fairman RM, Velazquez OC and Herlyn M. (2003). Mol. Cell Biol., 23, 14-25.
65. Logeat F, Bessia C, Brou C, LeBail O, Jarriault S, Seidah NG and Israel A. (1998). Proc. Natl. Acad. Sci. USA, 95, 8108-8112.
66. Lowell S, Jones P, Le R, I, Dunne J and Watt FM. (2000). Curr. Biol., 10, 491-500.
67. Mailhos C, Modlich U, Lewis J, Harris A, Bicknell R and Ish-Horowicz D. (2001). Differentiation, 69, 135-144.
68. Maine EM, Lissemore JL and Starmer WT. (1995). Mol. Phylogenet. Evol., 4, 139-149.
69. Matsuno K, Eastman D, Mitsiades T, Quinn AM, Carcanciu ML, Ordentlich P, Kadesch T and Artavanis-Tsakonas S. (1998). Nat. Genet., 19, 74-78.
70. Matsuno K, Ito M, Hori K, Miyashita F, Suzuki S, Kishi N, Artavanis-Tsakonas S and Okano H. (2002). Development, 129, 1049-1059.
71. Miele L, Bacon PE, Chaturvedi V, Qin J-L and Nickoloff BJ. (2000). J. Invest. Dermatol., 114, 758.
72. Miele L and Osborne BA. (1999). J. Cell Physiol., 181, 393-409.
73. Mizuguchi T, Hui T, Palm K, Sugiyama N, Mitaka T, Demetriou AA and Rozga J. (2001). J. Cell Physiol., 189, 106-119.
74. Mizutani T, Taniguchi Y, Aoki T, Hashimoto N and Honjo T. (2001). Proc. Natl. Acad. Sci. USA, 98, 9026-9031.
75. Moloney DJ, Panin VM, Johnston SH, Chen J, Shao L, Wilson R, Wang Y, Stanley P, Irvine KD, Haltiwanger RS and Vogt TF. (2000). Nature, 406, 369-375.
76. Mori S, Kadokawa Y, Hoshinaga K and Marunouchi T. (2003). Dev. Growth Differ., 45, 7-13.
77. Morrison SJ, Perez SE, Qiao Z, Verdi JM, Hicks C, Weinmaster G and Andersen DJ. (2000). Cell, 101, 499-510.
78. Mumm JS, Schroeter EH, Saxena MT, Griesemer A, Tian X, Pan DJ, Ray WJ and Kopan R. (2000). Mol. Cell, 5, 197-206.
79. Nair P, Somasundaram K and Krishna S. (2003). J. Virol., 77, 106-112.
80. Nakazawa M, Ishii H, Aono H, Takai M, Honda T, Aratani S, Fukamizu A, Nakamura H, Yoshino S, Kobata T, Nishioka K and Nakajima T. (2001). Arthritis Rheum., 44, 1545-1554.
81. Nickoloff BJ, Qin JZ, Chaturvedi V, Denning MF, Bonish B and Miele L. (2002). Cell Death Differ., 9, 842-855.
82. Nicolas M, Wolfer A, Raj K, Kummer JA, Mill P, Van Noort M, Hui CC, Clevers H, Dotto GP and Radtke F. (2003). Nat. Genet., 33, 416-421.
83. Oberg C, Li J, Pauley A, Wolf E, Gurney M and Lendahl U. (2001). J. Biol. Chem., 276, 35847-35853.
84. Ohishi K, Varnum-Finney B and Bernstein ID. (2002a). J. Clin. Invest, 110, 1165-1174.
85. Ohishi K, Varnum-Finney B and Bernstein ID. (2002b). Int. J. Hematol., 75, 449-459.
86. Ohishi K, Varnum-Finney B, Serda RE, Anasetti C and Bernstein ID. (2001). Blood, 98, 1402-1407.
87. Okajima T and Irvine KD. (2002). Cell, 111, 893-904.
88. Ordentlich P, Lin A, Shen CP, Blaumueller C, Matsuno K, Artavanis-Tsakonas S and Kadesch T. (1998). Mol. Cell. Biol., 18, 2230-2239.
89. Osborne BA. (2000). Curr. Opin. Immunol., 12, 301-306.
90. Osborne B and Miele L. (1999). Immunity, 11, 653-663.
91. Parks AL, Klueg KM, Stout JR and Muskavitch MA. (2000). Development, 127, 1373-1385.
92. Pear WS, Aster JC, Scott ML, Hasserjian RP, Soffer B, Sklar J and Baltimore D. (1996). J. Exp. Med., 183, 2283-2291.
93. Petcherski AG and Kimble J. (2000). Curr. Biol., 10, R471-R473.
94. Pui JC, Allman D, Xu L, DeRocco S, Karnell FG, Bakkour S, Lee JY, Kadesch T, Hardy RR, Aster JC and Pear WS. (1999). Immunity, 11, 299-308.
95. Qin J-Z, Chaturvedi V, Hendrix MJ, Seftor L, Denning MF, Weeraratna A, Bittner M, Trent J, Rizzo P, Miele L and Nickoloff BJ. (2003). J. Invest. Dermatol (in press).
96. Qiu L, Joazeiro C, Fang N, Wang HY, Elly C, Altman Y, Fang D, Hunter T and Liu YC. (2000). J. Biol. Chem., 275, 35734-35737.
97. Radtke F, Wilson A, Starke G, Bauer M, van Meerwijk J, Robson MacDonald H and Aguet M. (1999). Immunity, 10, 547-558.
98. Rae FK, Stephenson SA, Nicol DL and Clements JA. (2000). Int. J. Cancer, 88, 726-732.
99. Rand MD, Grimm LM, Artavanis-Tsakonas S, Patriub V, Blacklow SC, Sklar J and Aster JC. (2000). Mol. Cell. Biol., 2000, 20 1825-1835.
100. Rangarajan A, Syal R, Selvarajah S, Chakrabarti O, Sarin A and Krishna S. (2001a). Virology, 286, 23-30.
101. Rangarajan A, Talora C, Okuyama R, Nicolas M, Mammucari C, Oh H, Aster JC, Krishna S, Metzger D, Chambon P, Miele L, Aguet M, Radtke F and Dotto GP. (2001b). EMBO J., 20, 3427-3436.
102. Ronchini C and Capobianco AJ. (2000). Oncogene, 19, 3914-3924.
103. Ronchini C and Capobianco AJ. (2001). Mol. Cell Biol., 21, 5925-5934.
104. Rosenfield RL, Deplewski D and Greene ME. (2000). Horm. Res., 54, 269-274.
105. Royet J, Bouwmeester T and Cohen SM. (1998). EMBO J., 17, 7351-7360.
106. Ruiz-Hidalgo MJ, Garces C and Laborda J. (1999). Int. J. Oncol., 14, 777-783.
107. Santolini E, Puri C, Salcini AE, Gagliani MC, Pelicci PG, Tacchetti C and Di FP. (2000). J. Cell Biol., 151, 1345-1352.
108. Saxena MT, Schroeter EH, Mumm JS and Kopan R. (2001). J. Biol. Chem., 276, 40268-40273.
109. Shaye DD and Greenwald I. (2002). Nature, 420, 686-690.
110. Shelly LL, Fuchs C and Miele L. (1999). J. Cell Biochem., 73, 164-175.
111. Shimizu K, Chiba S, Hosoya N, Kumano K, Saito T, Kurokawa M, Kanda Y, Hamada Y and Hirai H. (2000). Mol. Cell. Biol., 20, 6913-6922.
112. Shimizu K, Chiba S, Saito T, Kumano K, Hamada Y and Hirai H. (2002). Biochem. Biophys. Res. Commun., 291, 775-779.
113. Struhl G and Adachi A. (1998). Cell, 93, 649-660.
114. Suzuki T, Aoki D, Susumu N, Udagawa Y and Nozawa S. (2000). Int. J. Oncol., 17, 1131-1139.
115. Swiatek PJ, Lindseil CE, del AF, Weinmaster G and Gridley T. (1994). Genes Dev., 8, 707-719.
116. Talora C, Sgroi DC, Crum CP and Dotto GP. (2002). Genes Dev., 16, 2252-2263.
117. Tohda S and Nara N. (2001). Leukamia. Lymphoma, 42, 467-472.
118. Varnum-Finney B, Brashem-Stein C and Bernstein ID. (2003). Blood, 101, 1784-1789.
119. Varnum-Finney B, Purton LE, Yu M, Brashem-Stein C, Flowers D, Staats S, Moore KA, Le RI, Mann R, Gray G, Artavanis-Tsakonas S and Bernstein ID. (1998). Blood, 91, 4084-4091.
120. Varnum-Finney B, Xu L, Brashem-Stein C, Nourigat C, Flowers D, Bakkour S, Pear WS and Bernstein ID. (2000). Nat. Med., 6, 1278-1281.
121. Wang W, Prince CZ, Mou Y and Pollman MJ. (2002). J. Biol. Chem., 277, 21723-21729.
122. Weijzen S, Rizzo P, Braid M, Vaishnav R, Jonkheer SM, Zlobin A, Osborne BA, Gottipati S, Aster JC, Hahn WC, Rudolf M, Siziopikou K, Kast WM and Miele L. (2002a). Nat. Med., 8, 979-986.
123. Weijzen S, Velders MP, Elmishad AG, Bacon PE, Panella JR, Nickoloff BJ, Miele L and Kast WM. (2002b). J. Immunol., 169, 4273-4278.
124. Weijzen S, Zlobin A, Braid M, Miele L and Kast WM. (2003). J. Cell Physiol., 194, 356-362.
125. Weng AP, Nam Y, Wolfe MS, Pear WS, Griffin JD, Blacklow SC and Aster JC. (2003). Mol. Cell. Biol., 23, 655-664.
126. Wilson A, Ferrero I, MacDonald HR and Radtke F. (2000). J. Immunol., 165, 5397-5400.
127. Wolfer A, Bakker T, Wilson A, Nicolas M, Ioannidis V, Littman DR, Lee PP, Wilson CB, Held W, MacDonald HR and Radtke F. (2001). Nat. Immunol., 2, 235-241.
128. Wu L, Aster JC, Blacklow SC, Lake R, Artavanis-Tsakonas S and Griffin JD. (2000). Nat. Genet., 26, 484-489.
129. Xia X, Qian S, Soriano S, Wu Y, Fletcher AM, Wang XJ, Koo EH, Wu X and Zheng H. (2001). Proc. Natl. Acad. Sci. USA, 98, 10863-10868.
130. Xue Y, Gao X, Lindsell CE, Norton CR, Chang B, Hicks C, Gendron-Maguire M, Rand EB, Weinmaster G and Gridley T. (1999). Hum. Mol. Genet., 8, 723-730.
131. Yamamoto N, Yamamoto S, Inagaki F, Kawaichi M, Fukamizu A, Kishi N, Matsuno K, Nakamura K, Weinmaster G, Okano H and Nakafuku M. (2001). J. Biol. Chem., 276, 45031-45040.
132. Yang Q, Bermingham NA, Finegold MJ and Zoghbi HY. (2001). Science, 294, 2155-2158.
133. Yasutomo K, Doyle C, Fuchs C, Miele L and Germain RN. (2000). Nature, 404, 506-510.
134. Zagouras P, Stifani S, Blaumueller CM, Carcangiu ML and Artavanis-Tsakonas S. (1995). Proc. Natl Acad. Sci. USA, 92, 6414-6418.
135. Zecchini V, Brennan K and Martinez-Arias A. (1999). Curr. Biol., 9,460-469.
136. Zhou S, Fujimuro M, Hsieh JC, Chen L, Miyamoto A, Weinmaster G and Hayward SD. (2000). Mol Cell. Biol., 20, 2400-2410.
137. Zlobin A, Jang M-S and Miele L. (2000). Curr. Pharm. Biotechnol., 1, 83-106.